Alex Sirois

Alex Sirois

Alex is a freelance contributor to InvestorPlace who provides investment insight that is conversational, actionable, and educational. While he writes about all stock classes, his personal stock investing style is focused on long-term, buy-and-hold, wealth-building stock picks.

Having worked in several industries from e-commerce to translation to education and utilizing his MBA from George Washington University, he brings a diverse set of skills through which he filters his writing. His number one goal in writing for InvestorPlace is to bring value to the reader.

You can follow Alex on LinkedIn.

Recent Articles

Atossa Therapeutics Might Shoot Up Quickly on Covid-19 Fear

ATOS stock is a relatively unknown pharmaceutical firm that is worth keeping an eye on due to surging Covid-19 cases.

QuantumScape Remains a Speculative Bet Far From Commercialization

QS stock remains interesting but not investment worthy due to the things that can still go wrong between now and the future.

Cleveland Cliffs Stock Looks Poised to Rally Over the Longer Term

Cleveland Cliffs' Q2 results weren't perfect, but CLF stock should get a boost from the federal infrastructure initiative.

Fisker Stock Is a Risk Worth Taking Given Its Manufacturing Plans

FSR stock recently solidified the best choice it's made in its young life. Now investors should see it for the wise play it is.

The Magneto Update Shouldn’t Move Ethereum Classic Prices Long-Term

Ethereum Classic has an upcoming update which is being touted as a catalyst to pay attention to. There's no much there.